Blog Post

Home > BHI News > Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine (Episode 2)

Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine (Episode 2)

by bluehorizon July 15, 2020

BHI News

23 / 35

Dr. Wu Summary On Coronavirus Study

BHI News

Brian Mehling, MD, (R) and Dongecheng Wu, MD, Ph.D., (L) during the stem cell applications at BHI Jamaica.

BHI News

Brian Mehling, MD presented at the Annual Congress of Society for Brain Mapping & Therapeutics in Los Angeles

BHI News

Social Media

About Us

BHI Rejuve is a hormone optimization program where each patient is evaluated with an extensive assessment of labs. After all labs are completed by the patient, a comprehensive evaluation of the results is conducted; if necessary, patients are put on a hormone optimization program which is personalized for each individual.

Find Us

Long Island Location:
800 Montauk Highway, West Islip, NY, 11795
Phone Number: 1-855-553-8500

NYC Location:
330 E 38th Street, PH57jk, New York, NY, 10016

Hackensack Location:
214 State St, Suite 101 Hackensack, NJ 07601

Blog Post

Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine (Episode 2)

Related Posts

Dr. Wu Summary On Coronavirus Study

Brian Mehling, MD, (R) and Dongecheng Wu, MD, Ph.D., (L) during the stem cell applications at BHI Jamaica.

Brian Mehling, MD presented at the Annual Congress of Society for Brain Mapping & Therapeutics in Los Angeles

Categories

Social Media